Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

IUT gains Oncologix radiation therapy tech

This article was originally published in Clinica

Executive Summary

German analytic device manufacturer Institut für Umwelttechnologien (IUT) is set to add Oncologix Tech’s Oncosphere brachytherapy device to its product portfolio for a fee of $50,000. In return for all the assets of the product, Oncologix will receive a 20% equity in IUT Medical, a newly-formed subsidiary of IUT which will assume the Oncosphere. Oncologix will also receive royalties based on IUT Medical’s future revenues. The Oncosphere uses a radioactive micro-particle designed to deliver therapeutic radiation directly to soft tissue cancers.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT042961

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel